Assessment of a Serum Assay for Quantification of Abdominal Aortic Calcification
Paula Clancy, Lisa Oliver, Rumal Jayalath, Petra Buttner, Jonathan Golledge I ntimal vascular calcification is an important marker of atherosclerosis, and its severity is an independent risk factor for cardiovascular events. 1 Measurement of coronary or aortic calcification requires CT-based imaging and elaborate data analysis to ensure accuracy. 2 A blood assay which could quantify the severity of vascular calcification would be less expensive, avoid exposure to radiation, and be more accessible than present imaging based methods. Osteoprotegerin (OPG) and osteopontin (OPN) are present in human serum and have been implicated in vascular calcification. 3, 4 In this prospective study we assessed the value of a number of serum assays for OPG and OPN in determining abdominal aortic calcification. Firstly, we investigated the assay characteristics and reproducibility of 5 ELISAs using a subset of patients. Based on the findings of these assessments, we selected 3 assays for full evaluation in the entire cohort.
Methods
One hundred and nine patients with peripheral vascular disease had fasting serum obtained the morning before measurement of infrarenal abdominal aortic calcification. We assessed a variety of different commercial ELISAs (details are given in the supplemental Methods, available online at http://atvb.ahajournals.org).
Results

Assessment of Assay Characteristics
We identified a large number of commercial ELISAs for OPG with varying reported assay characteristics (see supplemental Methods). We initially compared the OPG ELISAs in terms of recognized assay requirements. 5 The calibration curves and linearity of the assays were excellent (supplemental Table I ). Concordance correlation coefficients for intraand inter-assay reproducibility were good but most reproducible for the DuoSet assay (supplemental Table II ). Each OPG assay uses a different form of OPG as a reference standard (supplemental Figure I) . As a measure of accuracy we assessed the ability of the different assays to recognize added OPG spiked into serum. The mean recovery was 57Ϯ7.5%, 83Ϯ5.0%, and 58Ϯ9.0% for the Duoset, Biovendor, and Biomedica ELISAs, respectively (nϭ8 for each assay). The physiological ligand RANKL had little effect on the assay results (see supplemental Results). Two assays for serum OPN were assessed (Quantikine R&D Systems and IBL Immuno-Biological Laboratories). We found similar assay characteristics for these kits (mean recovery 90Ϯ4.5% and 88.3Ϯ9.1%, intra-and inter-assay concordance correlation coefficient 0.990 to 0.994).
Comparison of Serum OPG and OPN in Determining Aortic Calcification
We assessed the ability of serum OPG assessed with both BioVendor and DuoSet ELISAs and OPN measured with the R&D quantikine kit to predict abdominal aortic calcification. The characteristics of the patients entered into the study are shown in supplemental (Figure, a) . Patients were divided into quartiles based on volume of aortic calcification. Serum OPG but not OPN was related to calcification quartile (Figure, b) . Receiver operating characteristic curves demonstrated that a cut-off value of OPG of 72 pM (DuoSet; sensitivity 85%, specificity 55%, negative predictive value 92% based on prevalence of 25%, area under the curve 0.68, 95% CI 0.58 to 0.79, Pϭ0.004) and 8.49 pM (Biovendor; sensitivity 56%, specificity 76%, negative predictive value 84% based on prevalence of 25%, area under the curve 0.67, 95% CI 0.56 to 0.79, Pϭ0.007) were the most accurate in determining the highest quartile of aortic calcification (Figure, c) .
Comparison of the DuoSet and BioVendor ELISA
The serum OPG concentrations measured by the two OPG ELISAs were noted to be very different with limited concordance between values (Table) . To further investigate these differences the 109 serum samples and opposing manufacturer's standards were assessed in each assay. These results allowed the calculation of the concentration of the serum samples by reference to the two different standards in each assay separately. Using the supplied standards to calculate results the mean (Ϯstandard deviation), OPG concentrations for the samples were 78.4Ϯ32.4 and 7.59Ϯ2.75 pM in the Duoset and Biovendor ELISAs, respectively. The difference in values were markedly reduced by the use of similar standards in the different ELISA plates; eg, using Biovendor standards to read the Duoset and Biovendor ELISAs resulted in mean serum OPG concentrations of 9.73Ϯ5.86 and 7.59Ϯ2.75, respectively (Table) .
Discussion
A number of previous studies have assessed the association of serum calcification markers, such as osteoprotegerin and osteopontin, with abdominal aortic calcification. 1,3,4,6 -8 In many of these studies the reproducibility and accuracy of the assessment methods has not been quantitated, with a number of investigators relying on subjective techniques such as plain X-ray. 3 Other studies have only involved small numbers of patients 4, 6, 8 or were reserved to those patients with renal failure. 7 In this study we used a carefully validated CT protocol to accurately measure the volume of infrarenal aortic calcification and, in addition, thoroughly assessed the assay characteristics for our calcification markers (supplemental Tables I and II) . 2 We found an association between serum concentrations of OPG but not OPN and severity of infrarenal abdominal aortic calcification ( Figure) . The association suggests the potential value of serum assays for OPG in predicting aortic calcification and cardiovascular risk. Indeed, serum concentrations of OPG have been related to cardiovascular events. 9 However, our study also emphasized that at present the available commercial ELISAs for OPG have a number of differences with marked variation in calculated serum concentrations with different assays (Table) . These variations appear largely attributable to differences in the standards used in the ELISAs (Table; supplemental Figure I ). Which assay gives values closest to true serum OPG requires further assessment, but the greater similarity of the DuoSet standard to full-length OPG suggests this ELISA may be more representative. Further improvements in OPG assays may lead to better sensitivity and specificity in detecting significant aortic calcification and allow the assay to become clinically useful. The relatively low cost of the DuoSet ELISA supports the use of this assay in large screening studies.
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A, Scatter plot of relationship between serum OPG (measured with biovendor assay) and infrarenal abdominal aortic calcification severity. B, Relationship between serum OPG concentration (measured with DuoSet assay) and quartile of abdominal aortic calcification severity. Shown are box plots representing median and interquartile range for patients with different quartiles of aortic calcification. C, Receiver operating characteristic curve for serum OPG (measured with both DuoSet and BioVendor assays) in determining the highest quartile of abdominal aortic calcification.
Comparison Between Serum OPG Measured by DuoSet and Biovendor ELISAs
CCC ͓95%-CI͔* Bias** r (P value)*** *CCC ͓95%-CI͔ϭConcordance correlation coefficient and 95%-confidence interval. **Biasϭmean difference (standard deviation of differences). ***rϭPearson correlation coefficient for correlation between average and mean differences of values and respective P value.
Values in bold are those obtained using the standards provided with the relevant assay while those in italics are using the other manufacturers standards. ligand for OPG and present in the serum at 0.019-7.6pM [10] [11] [12] [13] [14] [15] . We assessed the interference of adding 10pM of RANKL to different concentrations of OPG standards in the three different ELISAs. Every sample (n=40) and standards (n=8, 7, 5 for Duoset, Biovendor and Biomedica, respectively) were assayed in duplicate to assess intra-assay variability on two separate days. Samples (n=35) were assayed on two different days to assess inter-assay variability.
Data analysis:
Clinical and laboratory data were prospectively entered into a spreadsheet (Microsoft Excel) and later transferred to SPSS (Version 13.0) for Windows for further analysis. Assay precision were assessed using concordance correlation coefficients (CCC) with 95%-confidence intervals (95%-CI), scatter plots comparing the observed values against the line of equality, Pearson's correlation coefficient (r), standard deviation and Bland-Altman residual plots [16, 17] . The relationships between measured serum OPG and OPN and aortic calcification were assessed by an independent researcher by means of scatter plots, Spearman rank order correlation, box plots and Kruskal Wallis test. In order to determine the cut-off OPG concentration with most accuracy (combined sensitivity and specificity) in distinguishing the patients with aortic calcification of the upper quartile, receiver operating characteristic (ROC) curves were created and area under the curve (AUC) calculated. Table I illustrates the standard and sample curve parameters for the OPG assays. The intra and inter-assay reproducibility of the OPG assays is shown in Supplemental Table II [16] ; **Bias = mean difference (∀ standard deviation of differences) [17] ; ***r = Pearson's correlation coefficient for correlation between average and mean differences of values and respective p-value [17] . 
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